Archive of Members
We are proud to connect so many ILD minded WASOG members all over the world.
WASOG is committed to strengthening mutual contact and providing information about ILD.
Read more about all our members on this page. Together we can achieve more.

Goran Nadir Salih
Senior Consultant Pulmonologist, Sleep and Internal Medicine Danish Board Certified in Internal and Pulmonary Medicine Director of Pulmonary Subspecialty and Interventional Pulmonology Clinic Rashid Hospital, Dubai Health Clinical Associate Professor of M
Rashid University Hospital Dubai Health Umm Hurair the Second Dubai, United Arab Emirates MBRU, Al Razi St, Dubai HealthCare City
Interstitial Lung Diseases, Lung Cancer, Interventional Pulmonology, Airway Diseases , Respiratory Infection, Pleural Diseases, Pre and Post Graduate Clinical Education
Thomas Gavin
Dr, consultant in respiratory medicine
Bart's Health NHS Trust,Respiratory medicine,St Bartholomew’s Hospital, London,EC1A 7B, United Kingdom,
ILD, Sarcoidosis

Tevfik Ismail
Consultant Cardiologist/Reader (Associate Professor)
Guy's and St Thomas' Hospital/King's College London, Cardiology Department, St Thomas' Hospital, London SE1 7EH, United Kingdom of Great Britain and Northern Ireland,
nflammatory Cardiomyopathy, Myocarditis, Cardiovascular Magnetic Resonance Imaging, EGPA, Autoimmune Disease, Sarcoid, Cardio-rheumatology, Pericarditis
Mark Jones
Professor of Respiratory Medicine
University of Southampton, NIHR Southampton Biomedical Research Centre, United Kingdom
Vasileios Kouranos
PhD, MSc, MD, FRCP Consultant Respiratory Physician
Royal Brompton Hospital, Interstitial Lung Disease, Sydney street London SW3 6NP
Advanced pulmonary and cardiac sarcoidosis
Beatriz Lara
Dr, MD, PhD
Coventry University Hospital (Coventry&Warwickshire NHS Trust), Respiratory Medicine, Third floor, East Wing, Coventry University hospital, Clifford Bridge Road, CV2 2DX, United Kingdom
Rare respiratory diseases
Giulia Montrasio
Doctor
St Bartholomew's Hospital, Cardiomyopathy, West Smithfield, London, EC1A 7BE, United Kingdom
Cardiomyopathy, Cardiology, Cardiac Sarcoidosis
Deepak Nagra
Rheumatology SpR & Clinical Trials Fellow
King's College Hospital, Rheumatology, King'College Hospital, London, UK University Hospitals Coventry & Warwickshire, Coventry, UK
Multi-system Sarcoidosis, Inflammatory Arthritis,IgG4 Disease, Phase 2/3 clinical trials, Immunology of rheumatic disease, Vaccinology

Anne-Marie Russell
Professor ILD / Nursing Science
University of Birmingham, College of Medicine and health, Edgbaston, Birmingham, B15 2TT, United Kingdom
Dr Russell has research expertise in mixed methods approaches, patient reported measures, person-centered approaches and supported self-management in interstitial lung diseases.
Noor Sharrack
Clinical fellow in cardiomyopathy
Barts Heart Centre, Barts Heart Centre, St Bartholomew’s Hospital, EC1A 7BE, United Kingdom
Cardiac sarcoidosis CMR Imaging

Juan Carlos Quijano-Campos
HEE-NIHR-ICA Clinical Doctoral Research Fellow (WHRI, QMUL); Honorary Clinical Doctoral Research Fellow (St Bartholomew’s Hospital, Barts Health NHS Trust); Honorary Research Fellow (Royal Papworth Hospital NHS Foundation Trust)
Queen Mary University of London / Barts Health NHS Trust;William Harvey Research Institute / Inherited Cardiovascular Disease Unit;St Bartholomew’s Hospital, Barts Health NHS Trust, West Smithfield, London EC1A 7DN, UK
Sarcoidosis; Cardiac sarcoidosis; RGN BSc (Hon) MSc (Hon); Nurse researcher; Senior Clinical Research Nurse/Senior Research Coordinator; Clinical Specialist Nurse; Research focus: Health-related quality of life (HRQoL) in sarcoidosis
Kesavaperumal Vijayasaratha
Dr. Consultant Respiratory
National Health Service, Northampton General hospital, UK, MEDICINE, Cliftonville, Northampton, NN1 5BD, UK, NN1 5BD, UNITED KINGDOM,
Sarcoidosis, EGPA, ILD

Athol Wells
Professor
Royal Brompton Hospital, Interstitial Lung Disease Unit, 3 Whistlers Avenue, SW11 3TS, United Kingdom
Prognostic evaluation in diffuse lung disease using HRCT and pulmonary function tests. The definition of relationships between structure and function in diffuse lung disease. The definition of disease type and severity in genetic and laboratory studies. Studies of new therapies in diffuse lung disease.

Lynne Williams
Dr (Consultant Cardiologist
Royal Papworth Hospital, Cardiology, Cambridge Biomedical Campus, Cambridge CB2 0AY, United Kingdom
Cardiac Sarcoidosis Inflammatory cardiomyopathies Genetic cardiomyopathi

Hakim Azfar Ali
Director, Duke Pulmonary Sarcoid Clinic
Duke University Hospital, Internal Medicine, Division of Pulmonary, Allergy and Critical Care, 40 Medicine Circle, Durham NC 27710, USA
Sarcoid and Lung Transplant

Adam Anderson
Associate Professor
Washington University in St. Louis, Medicine, 660 S Euclid Avenue Box 8052, St. Louis, MO 63110, United Stated
Multisystemic sarcoidosis with an emphasis on clinical management of pulmonary and cardiac sarcoidosis.

Shambhu Aryal
Director, Inova Sarcoidosis Center; Medical Director, Inova Lung Transplant Program
Inova Health System, Inova Heart and Vascular Institute, 3300 Gallows Rd, Fairfax, VA 22042, USA
Sarcoidosis, Lung Transplantation
Christian Ascoli
Assistant Professor of Medicine
University of Illinois at Chicago, Department of Medicine; Division of Pulmonary, Critical Care, Sleep, and Allergy, 1801 W Taylor St. Suite 3C (MC 755), Chicago, IL 60612, USA
Sarcoidosis/ILD

Umair Ashraf
Assistant Professor
Houston Methodsit Hospital, Pulmonary and Critical Care Medicine, Houston Methodsit Hospital, Houston , 77030, United States, Sarcoidosis
Sarcoidosis Interstitial Lung diseases Granulomatous Lung Diseases Idiopathic Pulmonary Fibrosis Connective Tissue Disease associated ILD Lymphangioleiomyomatosis
Jehad Azar
Dr.
Mayo Clinic Hopsital, Pulmonary and Critical Care, 15850 North Thompson Peak parkway, 85260, USA
Interstitial lung disease Sarcoidosis Pulmonary Hypertension